Skip to main content

Table 2 Odds ratios (OR) for remission of obesity-associated comorbidities and its components between surgery groups (SG vs.GB) at 6-, 12- and 24-months follow-up

From: Two-year outcomes of sleeve gastrectomy versus gastric bypass: first report based on Tehran obesity treatment study (TOTS)

Obesity-comorbidities Follow up (months) Propensity score-adjusted OR 95% CI P value
T2DM remission 6 0.82 0.51–1.31 0.412
12 1.15 0.69–1.91 0.574
24 2.00 0.88–4.54 0.096
HTN remission 6 0.79 0.56–1.10 0.169
12 0.96 0.68–1.36 0.850
24 2.10 1.22–3.60 0.007
Dyslipidemia remission 6 1.30 1.00–1.69 0.044
12 1.86 1.47–2.35 0.000
24 2.59 1.58–4.24 0.000
  1. T2DM Type 2 diabetes mellitus, HTN hypertension